Matches in Nanopublications for { ?s ?p "[A phase II study of the peroxisome proliferator-activated receptor-? agonist rosiglitazone extended release (RSG XR) in mild-to-moderate Alzheimer's disease (AD) detected a treatment benefit to cognition in apolipoprotein E(APOE)-?4-negative subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[A phase II study of the peroxisome proliferator-activated receptor-? agonist rosiglitazone extended release (RSG XR) in mild-to-moderate Alzheimer's disease (AD) detected a treatment benefit to cognition in apolipoprotein E(APOE)-?4-negative subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A phase II study of the peroxisome proliferator-activated receptor-? agonist rosiglitazone extended release (RSG XR) in mild-to-moderate Alzheimer's disease (AD) detected a treatment benefit to cognition in apolipoprotein E(APOE)-?4-negative subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.